These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6164969)

  • 21. Development of maternal antibodies after oral vaccination of young female wild boar against classical swine fever.
    Kaden V; Lange E
    Vet Microbiol; 2004 Oct; 103(1-2):115-9. PubMed ID: 15381274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yellow fever vaccines, a consideration of different types and their field trials.
    MACNAMARA FN
    West Afr Med J; 1955 Sep; 4(3):124-9. PubMed ID: 13274776
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo.
    Rau H; Revets H; Balmelli C; McCullough KC; Summerfield A
    Vet Res; 2006; 37(1):155-68. PubMed ID: 16336932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral and cell-mediated immune responses of d/d histocompatible pigs against classical swine fever (CSF) virus.
    Piriou L; Chevallier S; Hutet E; Charley B; Le Potier MF; Albina E
    Vet Res; 2003; 34(4):389-404. PubMed ID: 12911856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Difference between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek's disease vaccines.
    King D; Page D; Schat KA; Calnek BW
    Avian Dis; 1981; 25(1):74-81. PubMed ID: 6268052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation of protein content by biuret method during production of Yellow Fever Vaccine.
    Shrivastaw KP; Singh S; Sharma SB; Sokhey J
    Biologicals; 1995 Dec; 23(4):299-300. PubMed ID: 8825858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses.
    Ellis JA; Bogdan JR; Kanara EW; Morley PS; Haines DM
    J Am Vet Med Assoc; 1995 Mar; 206(6):823-32. PubMed ID: 7538990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Report of a serological survey of Cape Verdeans living on the island of São Nicolau and in New England, U.S.A. Treponematosis, yellow fever and tetanus antibodies.
    Florey Cdu V; Borman EK; Henderson JR; Levine L
    An Esc Nacl Saude Publica Med Trop (Lisb); 1968; 2(1):3-9. PubMed ID: 5734849
    [No Abstract]   [Full Text] [Related]  

  • 30. [Epidemiology of hepatitis A and B and yellow fever in Zaire].
    Werner GT; Fresenius K; Frösner GG; Huber HC
    Fortschr Med; 1984 Oct; 102(40):1019-21. PubMed ID: 6334010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
    Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
    Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vaccination against infectious laryngotracheitis of chickens: determination of immunity following eyedrop or spray vaccination using serology and challenge infections].
    Redmann T; Buken B; Kaleta EF; Lüders H; Siegmann O
    Dtsch Tierarztl Wochenschr; 1983 Apr; 90(4):137-41. PubMed ID: 6305625
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vaccination against infectious laryngotracheitis of chickens: summarizing report of a field trial].
    Kaleta EF; Dunger F; Buken B; Redmann T
    Dtsch Tierarztl Wochenschr; 1983 Apr; 90(4):142-7. PubMed ID: 6305626
    [No Abstract]   [Full Text] [Related]  

  • 34. [Testing of 2 vaccines against infectious bovine rhinotracheitis].
    Lazarowicz M; Steck F; Ackermann M; Kihm U
    Schweiz Arch Tierheilkd; 1983 Nov; 125(11):797-808. PubMed ID: 6318308
    [No Abstract]   [Full Text] [Related]  

  • 35. Serological responses of patas monkeys (Erythrocebus patas) to vaccination against cholera and yellow fever.
    Felsenfeld O; Wolf RH; Dutta NK
    Proc Soc Exp Biol Med; 1973 Jun; 143(2):548-50. PubMed ID: 4196722
    [No Abstract]   [Full Text] [Related]  

  • 36. [A study on immunogenicity and safety of bivalent inactivated vaccine against hemorrhagic fever with renal syndrome].
    Ruan Y; Xu X; Liu W; Deng X; Weng S; Zhou W; Wang Q; Chen L; Fang L; Xu Z; Yan Q; Liu W; Dong G; Gu H; Yu Y; Xu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Nov; 33(6):340-2. PubMed ID: 11864504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of effectiveness of FMD vaccine type Asia 1 in neutralization tests in cattle].
    Dimitriadis IA
    Berl Munch Tierarztl Wochenschr; 1993 Apr; 106(4):124-7. PubMed ID: 8387775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and efficacy of an inactivated subunit vaccine against Aujeszky's disease virus infection.
    Turner SP; Hartley CE; Buchan A; Skinner GR
    Res Vet Sci; 1981 Sep; 31(2):261-3. PubMed ID: 6275479
    [No Abstract]   [Full Text] [Related]  

  • 39. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle.
    Platt R; Coutu C; Meinert T; Roth JA
    Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.
    Hepburn MJ; Kortepeter MG; Pittman PR; Boudreau EF; Mangiafico JA; Buck PA; Norris SL; Anderson EL
    Vaccine; 2006 Apr; 24(15):2843-9. PubMed ID: 16494976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.